While shareholders of CorMedix (NASDAQ:CRMD) are in the black over 1 year, those who bought a week ago aren't so fortunate [Yahoo! Finance]
CorMedix Inc. (CRMD)
NASDAQ:AMEX Investor Relations:
cormedix.com
Company Research
Source: Yahoo! Finance
Like an eagle, the share price soared 188% in that time. So some might not be surprised to see the price retrace some. The real question is whether the business is trending in the right direction. In light of the stock dropping 23% in the past week, we want to investigate the longer term story, and see if fundamentals have been the driver of the company's positive one-year return. Check out our latest analysis for CorMedix Given that CorMedix didn't make a profit in the last twelve months, we'll focus on revenue growth to form a quick view of its business development. Generally speaking, companies without profits are expected to grow revenue every year, and at a good clip. As you can imagine, fast revenue growth, when maintained, often leads to fast profit growth. In the last year CorMedix saw its revenue grow by 41,184%. That's well above most other pre-profit companies. And the share price has responded, gaining 188% as we previously mentioned. That sort of revenue growth is
Show less
Read more
Impact Snapshot
Event Time:
CRMD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CRMD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CRMD alerts
High impacting CorMedix Inc. news events
Weekly update
A roundup of the hottest topics
CRMD
News
- CorMedix (CRMD) Upgraded to Strong Buy: What Does It Mean for the Stock? [Yahoo! Finance]Yahoo! Finance
- CorMedix Inc. to Participate in the Truist Securities BioPharma SymposiumGlobeNewswire
- Rainbows and Unicorns: CorMedix Inc. (NASDAQ:CRMD) Analysts Just Became A Lot More Optimistic [Yahoo! Finance]Yahoo! Finance
- CorMedix Inc. (NASDAQ: CRMD) was upgraded by analysts at StockNews.com to a "sell" rating.MarketBeat
- CorMedix Inc. (NASDAQ: CRMD) had its price target raised by analysts at Needham & Company LLC from $10.00 to $18.00. They now have a "buy" rating on the stock.MarketBeat
CRMD
Earnings
- 10/30/24 - Beat
CRMD
Sec Filings
- 11/18/24 - Form 4
- 11/14/24 - Form 144
- 11/14/24 - Form SC
- CRMD's page on the SEC website